0001123292-18-000552.txt : 20180321 0001123292-18-000552.hdr.sgml : 20180321 20180321170113 ACCESSION NUMBER: 0001123292-18-000552 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180209 FILED AS OF DATE: 20180321 DATE AS OF CHANGE: 20180321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Keefer Jason CENTRAL INDEX KEY: 0001717590 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32966 FILM NUMBER: 18705039 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001360886 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 710881115 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 443-545-1819 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2018-02-09 0 0001360886 OSIRIS THERAPEUTICS, INC. OSIR 0001717590 Keefer Jason 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 0 1 0 0 Interim President & CEO Incentive Stock Opton (right to buy) 6.80 2018-07-19 2027-07-18 Common Stock 16000 D 4,000 shares underlying this option shall vest on each of July 19, 2018, July 19, 2019, July 19, 2020 and July 19, 2021, subject to Reporting Person's continued service through the applicable vesting date. /s/ Jason Keefer 2018-03-21